AC
ZIVOW

Ayrton Capital’s Zivo Bioscience, Inc. Warrants ZIVOW Stock Holding History

Ayrton Capital’s Portfolio ZIVOW Stock Details ZIVOW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$21.9K Hold
48,850
– – 0.15% 25
2023
Q2 		$29.3K Hold
48,850
– – 0.18% 22
2023
Q1 		$28.5K Hold
48,850
– – 0.1% 31
2022
Q4 		$37.6K Hold
48,850
– – 0.1% 36
2022
Q3 		$29K Hold
48,850
– – 0.05% 56
2022
Q2 		$36K Hold
48,850
– – 0.06% 54
2022
Q1 		$31K Hold
48,850
– – 0.04% 81
2021
Q4 		$46K Buy
+48,850
New +$45.4K 0.04% 84

Other funds holding ZIVOW

WAM
Warberg Asset Management Winnetka, Illinois $600M AUM 23.37% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
VCA
Verdence Capital Advisors Hunt Valley, Maryland $1.72B AUM 24.88% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Ayrton Capital's ZIVOW Position: Q3 2023 in Review

Ayrton Capital held its Zivo Bioscience, Inc. Warrants (ZIVOW) position steady in Q3 2023 at 48,850 shares worth $21.9K. The position accounts for 0.15% of the portfolio, ranked #25.

Ayrton Capital first reported a position in ZIVOW in Q4 2021 and has held it in 8 quarters since. The position peaked at $46K in Q4 2021. 6 funds tracked by Wall St. Rank hold ZIVOW as of Q3 2023.

  • Ayrton Capital held 48,850 shares of Zivo Bioscience, Inc. Warrants worth $21.9K as of Q3 2023.
  • Ayrton Capital left its Zivo Bioscience, Inc. Warrants share count unchanged in Q3 2023.
  • Zivo Bioscience, Inc. Warrants made up 0.15% of Ayrton Capital's portfolio in Q3 2023, its #25 holding.
  • Ayrton Capital first reported a position in Zivo Bioscience, Inc. Warrants in Q4 2021 and has held it in 8 quarters since.
  • Ayrton Capital's Zivo Bioscience, Inc. Warrants position peaked at $46K in Q4 2021.
  • 6 funds tracked by Wall St. Rank held Zivo Bioscience, Inc. Warrants as of Q3 2023.

Based on Ayrton Capital's 13F filing for Q3 2023, filed 13 Nov 2023.